CD4 and neoplasm: Neoantigen vaccination was associated with a decrease in the percentage of regulatory T cells (Treg, CD4+CD25+FoxP3+) and, in particular, TIGIT+ Treg in the tumor (Figure 2D), likely due to the increased absolute number of tumor-infiltrating CD4 T cells (Figure 2A).